Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Decreases By 41.2%

Lexaria Bioscience Corp. (NASDAQ:LEXXWGet Free Report) was the target of a significant decrease in short interest during the month of February. As of February 28th, there was short interest totalling 2,000 shares, a decrease of 41.2% from the February 13th total of 3,400 shares. Based on an average daily volume of 9,100 shares, the days-to-cover ratio is currently 0.2 days.

Lexaria Bioscience Stock Performance

Shares of NASDAQ:LEXXW opened at $0.26 on Monday. Lexaria Bioscience has a 12-month low of $0.16 and a 12-month high of $2.07. The business has a 50 day moving average of $0.39 and a 200-day moving average of $0.69.

Lexaria Bioscience Company Profile

(Get Free Report)

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.

Featured Stories

Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.